Cheryl L. White is corporate vice president, quality at Baxter.
Prior to assuming this position, White served as vice president, quality management for Baxter's BioScience business in Westlake, California. She has held senior positions within the BioScience business with direct supervision over global manufacturing facilities and product development for biopharmaceutical products, biosurgery and vaccines. She played a vital leadership position in the successful validation, staffing and licensure of the ADVATE manufacturing facility in Neuchatel, Switzerland.
Before joining the company in 1998, she managed quality control and quality assurance activities for Hybritech, at the time a subsidiary of Eli Lilly and Beckman Instruments. In addition, she spent nine years in academic research in the University of California system.
White serves as the president of the Baxter International Foundation where she has been a member of the board of directors since 2006. She also is the executive sponsor of Baxter's Global Inclusion Council. She is a member of the Regulatory Affairs Professional Society (RAPS) and the Parenteral Drug Association (PDA).
White earned her master's degree in business administration from the University of California, Irvine, and a Bachelor of Arts in biology from the University of California, San Diego.
Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide.
Print this page
